IN THIS ISSUE

Susan Worley

Alzheimer’s and other dementias pose an enormous economic threat, but for now, the task force says, routine screening is unwarranted

Thomas Reinke

Health care systems join NIH in studying significance of mutations

Biologics in Development
Katherine T. Adams
Managing Editor's Memo
Frank Diamond
Medication Management
Thomas Reinke

Is it a simple matter of pay for volume vs. pay for value, or is the situation far more complicated?

The Formulary Files
Krishna Rutvij Patel, PharmD
Tomorrow's Medicine
Thomas Morrow, MD

Medication is aimed at leptin deficiency, but clinical trials may be hard for managed care plans to evaluate properly